Dr. PIAS: An integrative system for assessing the druggability of protein-protein interactions

BMC Bioinformatics

Volumn 12, Issue , 2011, Pages

  Sugaya, Nobuyoshi ^a   Furuya, Toshio ^a  

^a PharmaDesign Inc   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ASSESSMENT SYSTEM; BIOLOGICAL FUNCTIONS; HUMAN IMMUNODEFICIENCY VIRUS; MACHINE-LEARNING; NOVEL METHODOLOGY; PROTEIN-PROTEIN INTERACTIONS; PUBLIC DATABASE; TERTIARY STRUCTURES;

DATABASE SYSTEMS; DISEASES; SUPPORT VECTOR MACHINES; VIRUSES;

PROTEINS;

HUMAN IMMUNODEFICIENCY VIRUS; RATTUS;

HUMAN IMMUNODEFICIENCY VIRUS PROTEIN; PROTEIN;

ANIMAL; ARTICLE; CHEMISTRY; COMPUTER PROGRAM; HUMAN; METHODOLOGY; MOUSE; PHARMACEUTICS; PROTEIN ANALYSIS; PROTEIN DATABASE; RAT;

ANIMALS; DATABASES, PROTEIN; HUMAN IMMUNODEFICIENCY VIRUS PROTEINS; HUMANS; MICE; PROTEIN INTERACTION MAPPING; PROTEINS; RATS; SOFTWARE; TECHNOLOGY, PHARMACEUTICAL;

EID: 79651474672     PISSN: None     EISSN: 14712105     Source Type: Journal    
DOI: 10.1186/1471-2105-12-50     Document Type: Article

References (56)

1. Arkin MR, Wells JA. Small-molecule inhibitors of protein-protein interactions: progressing towards the dream. Nat Rev Drug Discov 2004, 3:301-317. 10.1038/nrd1343, 15060526.
2. Pagliaro L, Felding J, Audouze K, Nielsen SJ, Terry RB, Krog-Jensen C, Butcher S. Emerging classes of protein-protein interaction inhibitors and new tools for their development. Curr Opin Chem Biol 2004, 8:442-449. 10.1016/j.cbpa.2004.06.006, 15288255.
3. Zhao L, Chmielewski J. Inhibiting protein-protein interactions using designed molecules. Curr Opin Struct Biol 2005, 15:31-34. 10.1016/j.sbi.2005.01.005, 15718130.
4. Wells JA, McClendon CL. Reaching for high-hanging fruit in drug discovery at protein-protein interfaces. Nature 2007, 450:1001-1009. 10.1038/nature06526, 18075579.
5. Sugaya N, Ikeda K, Tashiro T, Takeda S, Otomo J, Ishida Y, Shiratori A, Toyoda A, Noguchi H, Takeda T, Kuhara S, Sakaki Y, Iwayanagi T. An integrative in silico approach for discovering candidates for drug-targetable protein-protein interactions in interactome data. BMC Pharmacol 2007, 7:10. 10.1186/1471-2210-7-10, 2045083, 17705877.
6. Sugaya N, Ikeda K. Assessing the druggability of protein-protein interactions by a supervised machine-learning method. BMC Bioinformatics 2009, 10:253. 10.1186/1471-2105-10-263, 2755483, 19686586.
7. Chen X, Ji ZL, Chen YZ. TTD: Therapeutic Target Database. Nucleic Acids Res 2002, 30:412-415. 10.1093/nar/30.1.412, 99057, 11752352.
8. Zhu F, Han B, Kumar P, Liu X, Ma X, Wei X, Huang L, Guo Y, Han L, Zheng C, Chen Y. Update of TTD: Therapeutic Target Database. Nucleic Acids Res 2010, 38:D787-791. 10.1093/nar/gkp1014, 2808971, 19933260.
9. Gao Z, Li H, Zhang H, Liu X, Kang L, Luo X, Zhu W, Chen K, Wang X, Jiang H. PDTD: a web-accessible protein database for drug target identification. BMC Bioinformatics 2008, 9:104. 10.1186/1471-2105-9-104, 2265675, 18282303.
10. Dunkel M, Günther S, Ahmed J, Wittig B, Preissner R. SuperPred: drug classification and target prediction. Nucleic Acids Res 2008, 36:W55-W59. 10.1093/nar/gkn307, 2447784, 18499712.
11. Bourgeas R, Basse MJ, Morelli X, Roche P. Atomic analysis of protein-protein interfaces with known inhibitors: the 2P2I database. PLoS ONE 2010, 5:e9598. 10.1371/journal.pone.0009598, 2834754, 20231898.
12. Higueruelo AP, Schreyer A, Bickerton GR, Pitt WR, Groom CR, Blundell TL. Atomic interactions and profile of small molecules disrupting protein-protein interfaces: the TIMBAL database. Chem Biol Drug Des 2009, 74:457-467. 10.1111/j.1747-0285.2009.00889.x, 19811506.
13. Toogood PL. Inhibition of protein-protein association by small molecules: approaches and progress. J Med Chem 2007, 45:1543-1558.
14. Loregian A, Palù G. Disruption of protein-protein interactions: towards new targets for chemotherapy. J Cell Physiol 2005, 204:750-762. 10.1002/jcp.20356, 15880642.
15. Fletcher S, Hamilton AD. Protein-protein interaction inhibitors: small molecules from screening techniques. Curr Top Med Chem 2007, 7:922-927. 10.2174/156802607780906735, 17508923.
16. LIBSVM-A Library for Support Vector Machines-. , http://www.csie.ntu.edu.tw/~cjlin/libsvm/
17. Maglott D, Ostell J, Pruitt KD, Tatusova T. Entrez Gene: gene-centered information at NCBI. Nucleic Acids Res 2007, 35:D26-D31. 10.1093/nar/gkl993, 1761442, 17148475.
18. Genome Network Platform. , http://genomenetwork.nig.ac.jp/download/dataset_e.html
19. Stelzl U, Worm U, Lalowski M, Haenig C, Brembeck FH, Goehler H, Stroedicke M, Zenkner M, Schoenherr A, Koeppen S, Timm J, Mintzlaff S, Abraham C, Bock N, Kietzmann S, Goedde A, Toksöz E, Droege A, Krobitsch S, Korn B, Birchmeier W, Lehrach H, Wanker EE. A human protein-protein interaction network: a resource for annotating the proteome. Cell 2005, 122:957-968. 10.1016/j.cell.2005.08.029, 16169070.
20. Lim J, Hao T, Shaw C, Patel AJ, Szabó G, Rual JF, Fisk CJ, Li N, Smolyar A, Hill DE, Barabási AL, Vidal M, Zoghbi HY. A protein-protein interaction network for human inherited ataxias and disorders of Purkinje cell degeneration. Cell 2006, 125:801-814. 10.1016/j.cell.2006.03.032, 16713569.
21. Ramani AK, Li Z, Hart GT, Carlson MW, Boutz DR, Marcotte EM. A map of human protein interactions derived from co-expression of human mRNAs and their orthologs. Mol Syst Biol 2008, 4:180. 10.1038/msb.2008.19, 2387231, 18414481.
22. Altschul SF, Madden TL, Schäffer AA, Zhang J, Zhang Z, Miller W, Lipman DJ. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res 1997, 25:3389-3402. 10.1093/nar/25.17.3389, 146917, 9254694.
23. Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE. The Protein Data Bank. Nucleic Acids Res 2000, 28:235-242. 10.1093/nar/28.1.235, 102472, 10592235.
24. Chemical Computing Group. , http://www.chemcomp.com/
25. Kabsch W, Sander C. Dictionary of protein secondary structure: pattern recognition of hydrogen-bonded and geometrical features. Biopolymers 1983, 22:2577-2637. 10.1002/bip.360221211, 6667333.
26. Dr. PIAS Help. , http://asp.gridasp.net/drpias/pias_help.php
27. Laskowski RA, Chistyakov VV, Thornton JM. PDBsum more: new summaries and analyses of the known 3 D structures of proteins and nucleic acids. Nucleic Acids Res 2005, 33:D266-268. 10.1093/nar/gki001, 539955, 15608193.
28. Finn RD, Mistry J, Tate J, Coggill P, Heger A, Pollington JE, Gavin OL, Gunasekaran P, Ceric G, Forslund K, Holm L, Sonnhammer EL, Eddy SR, Bateman A. The Pfam protein families database. Nucleic Acids Res 2010, 38:D211-D222. 10.1093/nar/gkp985, 2808889, 19920124.
29. Finn RD, Marshall M, Bateman A. iPfam: visualization of protein-protein interactions in PDB at domain and amino acid resolutions. Bioinformatics 2005, 21:410-412. 10.1093/bioinformatics/bti011, 15353450.
30. Neduva V, Linding R, Su-Angrand I, Stark A, de Masi F, Gibson TJ, Lewis J, Serrano L, Russell RB. Systematic discovery of new recognition peptides mediating protein interaction networks. PLoS Biol 2005, 3:e405. 10.1371/journal.pbio.0030405, 1283537, 16279839.
31. Hegyi H, Schad E, Tompa P. Structural disorder promotes assembly of protein complexes. BMC Struct Biol 2007, 7:65. 10.1186/1472-6807-7-65, 2194777, 17922903.
32. Fuxreiter M, Tompa P, Simon I. Local structural disorder imparts plasticity on linear motifs. Bioinformatics 2007, 23:950-956. 10.1093/bioinformatics/btm035, 17387114.
33. Kim PM, Sboner A, Xia Y, Gerstein M. The role of disorder in interaction networks: a structural analysis. Mol Sys Biol 2008, 4:179.
34. Cheng Y, LeGall T, Oldfield CJ, Mueller JP, Van YY, Romero P, Cortese MS, Uversky VN, Dunker AK. Rational drug design via intrinsically disordered protein. Trends Biotechnol 2006, 24:435-442. 10.1016/j.tibtech.2006.07.005, 16876893.
35. Lessene G, Czabotar PE, Colman PM. BCL-2 family antagonists for cancer therapy. Nat Rev Drug Discov 2008, 7:989-1000. 10.1038/nrd2658, 19043450.
36. Sun H, Nikolovska-Coleska Z, Yang CY, Xu L, Tomita Y, Krajewski K, Roller PP, Wang S. Structure-based design, synthesis, and evaluation of conformationally constrained mimetics of the second mitochondria-derived activator of caspase that target the X-linked inhibitor of apoptosis protein/caspase-9 interaction site. J Med Chem 2004, 47:4147-4150. 10.1021/jm0499108, 15293984.
37. Hirose S, Shimizu K, Kanai S, Kuroda Y, Noguchi T. POODLE-L: a two-level SVM prediction system for reliably predicting long disordered regions. Bioinformatics 2007, 23:2046-2053. 10.1093/bioinformatics/btm302, 17545177.
38. Gould CM, Diella F, Via A, Puntervoll P, Gemünd C, Chabanis-Davidson S, Michael S, Sayadi A, Bryne JC, Chica C, Seiler M, Davey NE, Haslam N, Weatheritt RJ, Budd A, Hughes T, Pas J, Rychlewski L, Travé G, Aasland R, Helmer-Citterich M, Linding R, Gibson TJ. ELM: the status of the 2010 eukaryotic linear motif resource. Nuclic Acids Res 2010, 38:D167-D180.
39. HMMER biosequence analysis using profile hidden Markov models. HMMER., http://hmmer.janelia.org/
40. Wishart DS, Knox C, Guo AC, Cheng D, Shrivastava S, Tzur D, Gautam B, Hassanali M. DrugBank: a knowledgebase for drugs, drug actions and drug targets. Nucleic Acids Res 2008, 36:D901-D906. 10.1093/nar/gkm958, 2238889, 18048412.
41. ChEMBL ChEMBL., http://www.ebi.ac.uk/chembldb/index.php
42. Hamosh A, Scott AF, Amberger JS, Bocchini CA, McKusick VA. Online Mendelian Inheritance in Man (OMIM), a knowledgebase of human genes and genetic disorders. Nucleic Acids Res 2005, 33:D514-D517. 10.1093/nar/gki033, 539987, 15608251.
43. Kanehisa M, Goto S, Furumichi M, Tanabe M, Hirakawa M. KEGG for representation and analysis of molecular networks involving diseases and drugs. Nucleic Acids Res 2010, 38:D355-D360. 10.1093/nar/gkp896, 2808910, 19880382.
44. Schaefer CF, Anthony K, Krupa S, Buchoff J, Day M, Hannay T, Buetow KH. PID: The Pathway Interaction Database. Nucleic Acids Res 2009, 37:D674-D679. 10.1093/nar/gkn653, 2686461, 18832364.
45. The Gene Ontology Consortium The Gene Ontology in 2010: extentions and refinements. Nucleic Acids Res 2010, 38:D331-D335. 10.1093/nar/gkp1018, 2808930, 19920128, The Gene Ontology Consortium.
46. Pontius JU, Wagner L, Schuler GD. UniGene: a unified view of the transcriptome. The NCBI Handbook 2003, Bethesda(MD): National Center for Biotechnology Information.
47. Wu CH, Nikolskaya A, Huang H, Yeh LS, Natale DA, Vinayaka CR, Hu ZZ, Mazumder R, Kumar S, Kourtesis P, Ledley RS, Suzek BE, Arminski L, Chen Y, Zhang J, Cardenas JL, Chung S, Castro-Alvear J, Dinkov G, Barker WC. PIRSF: family classification system at the Protein Information Resource. Nucleic Acids Res 2004, 32:D112-D114. 10.1093/nar/gkh097, 308831, 14681371.
48. Negishi Y, Nakamura H, Yachie N, Saito R, Tomita M. eXpanda: an integrated platform for network analysis and visualization. In Silico Biol 2007, 7:141-144.
49. Jmol: an open-source Java viewer for chemical structures in 3 D. , http://jmol.sourceforge.net/
50. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, Thun MJ. Cancer statistics, 2008. CA Cancer J Clin 2008, 58:71-96. 10.3322/CA.2007.0010, 18287387.
51. Lurje G, Lenz H-J. EGFR signaling and drug discovery. Oncology 2009, 77:400-410. 10.1159/000279388, 20130423.
52. Katzel JA, Fanucchi MP, Li Z. Recent advances of novel targeted therapy in non-small cell lung cancer. J Hematol Oncol 2009, 2:2. 10.1186/1756-8722-2-2, 2637898, 19159467.
53. Bogan AA, Thorn KS. Anatomy of hot spots in protein interfaces. J Mol Biol 1998, 280:1-9. 10.1006/jmbi.1998.1843, 9653027.
54. Brinda KV, Kannan N, Vishveshwara S. Analysis of homodimeric protein interfaces by graph-spectral methods. Protein Eng 2002, 15:265-277. 10.1093/protein/15.4.265, 11983927.
55. Dharmawardana PG, Peruzzi B, Giubellino A, Burke TR, Bottaro DP. Molecular targeting of growth factor receptor-bound 2 (Grb2) as an anti-cancer strategy. Anticancer Drugs 2006, 17:13-20. 10.1097/01.cad.0000185180.72604.ac, 16317285.
56. Garrett TP, McKern NM, Lou M, Elleman TC, Adams TE, Lovrecz GO, Zhu HJ, Walker F, Frenkel MJ, Hoyne PA, Jorissen RN, Nice EC, Burgess AW, Ward CW. Crystal structure of a truncated epidermal growth factor receptor extracellular domain bound to transforming growth factor alpha. Cell 2002, 110:763-773. 10.1016/S0092-8674(02)00940-6, 12297049.